Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Accentuate the Positive: Cramer's 'Mad Money' Recap (Monday 1/11/21)
By Scott Rutt
Jan 11, 2021 8:27 PM EST
JIM CRAMER
Accentuate the Positive: Cramer's 'Mad Money' Recap (Monday 1/11/21)
By Scott Rutt
Jan 11, 2021 8:27 PM EST
JIM CRAMER
Game Plan: Cramer's 'Mad Money' Recap (Friday 1/8/21)
By Scott Rutt
Jan 8, 2021 8:37 PM EST
PRESS RELEASES
Emergent BioSolutions To Participate In Investor Conferences
By GlobeNewswire
Jan 4, 2021 6:30 AM EST
INVESTING
Emergent BioSolutions Secures DOD Aid for Covid Treatment Test
By Dan Weil
Dec 30, 2020 11:21 AM EST
PRESS RELEASES
Emergent BioSolutions And Mount Sinai Health System Announce Initiation Of DOD-Funded Clinical Program To Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate For Prophylaxis
By GlobeNewswire
Dec 29, 2020 4:05 PM EST
JIM CRAMER
Reasons to Buy: Cramer's 'Mad Money' Recap (Wednesday 12/2/20)
By Scott Rutt
Dec 2, 2020 8:29 PM EST
HEALTH
Regeneron Covid Drug Gets Emergency OK
By Adam Smith
Nov 22, 2020 3:21 PM EST
LATEST NEWS
Sec. Alex Azar: Antibody Treatments, Vaccines 'Weeks' Away
By Adam Smith
Oct 18, 2020 4:39 PM EDT
PRESS RELEASES
Emergent BioSolutions To Release Third Quarter 2020 Financial Results And Conduct Conference Call On November 5, 2020
By GlobeNewswire
Oct 15, 2020 6:30 AM EDT
PRESS RELEASES
Emergent BioSolutions' COVID-19 Human Immune Globulin Product Candidate To Be Included In NIH-Sponsored Phase 3 Clinical Trial Of Hyperimmune Intravenous Immunoglobulin To Treat COVID-19
By GlobeNewswire
Oct 8, 2020 4:05 PM EDT
PRESS RELEASES
Emergent BioSolutions Teams Up With Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, And MAPDA To Highlight Importance Of Overdose Reversal Medicines On International Overdose Awareness Day
By GlobeNewswire
Aug 31, 2020 6:30 AM EDT
PRESS RELEASES
Emergent BioSolutions Announces Appointment Of Marvin White To The Company's Board Of Directors
By GlobeNewswire
Aug 26, 2020 6:30 AM EDT
INVESTING
AstraZeneca Kicks Off Covid-19 Antibody Trials
By M. Corey Goldman
Aug 25, 2020 10:09 AM EDT
LATEST NEWS
FDA OKs Plasma Treatment for Ill Covid-19 Patients
By Adam Smith
Aug 23, 2020 6:10 PM EDT
PRESS RELEASES
Emergent BioSolutions To Participate In Virtual Investor Conferences
By GlobeNewswire
Aug 18, 2020 6:31 AM EDT
JIM CRAMER
Splitsville: Cramer's 'Mad Money' Recap (Wednesday) 8/12/20)
By Scott Rutt
Aug 12, 2020 8:30 PM EDT
STOCKS
5 Stock Gainers for Wednesday: Novavax, Fiverr, Overstock.com
By Rob Lenihan
Aug 5, 2020 4:28 PM EDT
PRESS RELEASES
Emergent BioSolutions Announces Proposed Offering Of $400 Million Of Senior Unsecured Notes
By GlobeNewswire
Aug 4, 2020 8:00 AM EDT
JIM CRAMER
Great Buys: Cramer's 'Mad Money' Recap (Monday 8/3/20)
By Scott Rutt
Aug 3, 2020 8:52 PM EDT
PRESS RELEASES
Emergent BioSolutions Signs Agreement With AstraZeneca To Expand Manufacturing For COVID-19 Vaccine Candidate
By GlobeNewswire
Jul 27, 2020 6:30 AM EDT
JIM CRAMER
1999 All Over Again?: Cramer's 'Mad Money' Recap (Wednesday 7/22/20)
By Scott Rutt
Jul 22, 2020 9:51 PM EDT
PRESS RELEASES
Emergent BioSolutions Inc. To Be Added To The S&P MidCap 400 Index
By GlobeNewswire
Jul 21, 2020 4:45 PM EDT
PRESS RELEASES
Mount Sinai Health System, Emergent BioSolutions, And ImmunoTek Bio Centers Form Collaboration To Develop Emergent's COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate With U.S. Department Of Defense Funding
By GlobeNewswire
Jul 8, 2020 9:00 AM EDT
PRESS RELEASES
Emergent BioSolutions Signs Five-Year Agreement For Large-Scale Drug Substance Manufacturing For Johnson & Johnson's Lead COVID-19 Vaccine Candidate
By GlobeNewswire
Jul 6, 2020 6:30 AM EDT